An esophagobronchial fistula, an abnormal passageway formed between the esophagus and bronchus, can cause severe respiratory symptoms. This fistula is a complication that can occur during chemoradiotherapy for esophageal and lung cancers; however, to our knowledge, no esophagobronchial fistulas during preoperative chemotherapy for lung cancer have been reported. The patient was a 55-year-old man whose chest computed tomography (CT) revealed a mass on the dorsal bronchus and right side of the esophagus. A transesophageal needle biopsy confirmed the diagnosis of lung adenocarcinoma, and preoperative chemotherapy, which included pembrolizumab, was administered. One week after the first course of chemotherapy, the patient developed a severe cough after drinking water. Chest CT revealed an esophagobronchial fistula, which prompted the discontinuation of the preoperative chemotherapy. Subsequent conservative treatment resulted in no improvement, and the patient was referred to our department. One month thereafter, a two-stage reconstruction of the esophagus was performed via the posterior sternal route. The resected specimen showed no residual tumor in the lungs, and the treatment was determined to result in a complete pathological response. The patient is currently undergoing maintenance therapy with pembrolizumab as a single agent. This is a rare case of esophagobronchial fistula identified during preoperative chemotherapy that included pembrolizumab for lung cancer. In addition to suturing the fistula, filling it with a distal hyoid valve was effective in treating the esophagobronchial fistula.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11148842 | PMC |
http://dx.doi.org/10.7759/cureus.59666 | DOI Listing |
Cureus
May 2024
Thoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Asahikawa, JPN.
An esophagobronchial fistula, an abnormal passageway formed between the esophagus and bronchus, can cause severe respiratory symptoms. This fistula is a complication that can occur during chemoradiotherapy for esophageal and lung cancers; however, to our knowledge, no esophagobronchial fistulas during preoperative chemotherapy for lung cancer have been reported. The patient was a 55-year-old man whose chest computed tomography (CT) revealed a mass on the dorsal bronchus and right side of the esophagus.
View Article and Find Full Text PDFInterdiscip Cardiovasc Thorac Surg
July 2024
Department of Thoracic Surgery and Heart and Lung Transplantation, Hôpital Marie Lannelongue, Université Paris-Saclay, Le Plessis Robinson, France.
Objectives: Neo-oesophageal-airway fistula (NEAF) between gastric conduit and airway is a rare but life-threatening complication of oesophagectomy for oesophageal cancer. Optimal treatment remains unknown. A meta-analysis of good-quality case series may help determine whether nonoperative management (NOM) only, upfront surgery (S), or NOM followed by surgery is associated with better 1-year post-treatment mortality, resumption of oral diet and fistula recurrence.
View Article and Find Full Text PDFRev Gastroenterol Mex (Engl Ed)
April 2024
Departamento de Endoscopia Gastrointestinal, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Ciudad de México, Mexico.
Int J Surg Case Rep
February 2024
Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, 7-15 Kita-ku, Sapporo, Hokkaido 060-8638, Japan. Electronic address:
Introduction: Soft coagulation is a hemostatic system of electrosurgical units that automatically regulates its output to avoid carbonization or incision. This system is widely used in invasive procedures, including thoracic surgery. Few reports exist on the harmful effects of these devices.
View Article and Find Full Text PDFSci Rep
June 2023
Department of Human Genetics, Yokohama City University Graduate School of Medicine, Fukuura 3-9, Kanazawa-ku, Yokohama, 236-0004, Japan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!